Anika Therapeutics (ANIK) Stock Price, Quote, News & History

Comments

Anika Therapeutics Inc (ANIK) Stock Price, Quote, News & History

ANIKNASDAQ

Trade with Public

$14.28

-0.47-3.19%

At close: Mar 27, 5:00 PM EST

$14.28

N/A

After Hours: 4:00 PM EST

OverviewNews Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$14.72

Close

$14.28

Volume / Avg.

91.77K / 146.36K

Day Range

$14.19 - $14.73

52 Wk Range

7.87 - 15.79

Market Cap

$205.89M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

5.8%

Days to Cover

4.85

Recent Anika Therapeutics Inc News

Top 2 Health Care Stocks That May Crash This Quarter

2 stocks in healthcare sector flashing warning to investors who value momentum. RSI is an indicator that compares stock strength on up and down days.

Avi Kapoor

Anika Therapeutics Cingal Tops Steroid For Osteoarthritis Pain Relief

Vandana Singh

New FDA 510(k) Clearance Expands Anika's Sports Medicine Soft Tissue Portfolio

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

11.19M

Investing Cash Flow (TTM)

-401.00K

Financing Cash Flow (TTM)

-10.55M

Free Cash Flow (TTM)

4.36M

Capital Expenditure (TTM)

-6.83M

Net Change in Cash (TTM)

236.00K

Analyst Trends and Forecast

1

Nov 25

1

Jan

1

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.4

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$166.56M

PE Ratio (TTM)

-

PE Ratio (FWD)

59.17

PEG Ratio (TTM)

5.90

PS Ratio (TTM)

1.88

PB Ratio (TTM)

1.38

Earnings Yield % (TTM)

-4.74%

Earnings Yield % (FWD)

1.69%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

48.52

Book Value / Share

$10.71

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$57.48M

Debt to Equity

0.18

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$14.72

Close

$14.28

Volume / Avg.

91.77K / 146.36K

Day Range

$14.19 - $14.73

52 Wk Range

7.87 - 15.79

Market Cap

$205.89M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

5.8%

Days to Cover

4.85

About

Sector

Health Care

Industry

Biotechnology

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Anika Therapeutics (ANIK) stock?

A

You can purchase shares of Anika Therapeutics (NASDAQ:ANIK) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Anika Therapeutics (ANIK) competitors?

A

Other companies in Anika Therapeutics’s space includes: Macrogenics Inc (NASDAQ:MGNX), Atrium Therapeutics Inc (NASDAQ:RNA), Voyager Therapeutics Inc (NASDAQ:VYGR), Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) and Connect Biopharma Holdings Ltd (NASDAQ:CNTB).

Q

What is the forecast, or price target, for Anika Therapeutics (ANIK) stock?

A

Anika Therapeutics has a consensus price target of $20.50.

Q

What is the current price for Anika Therapeutics (ANIK)?

A

The stock price for Anika Therapeutics (NASDAQ: ANIK) is $14.28 last updated March 27, 2026 at 4:00 PM EDT.

Q

Does Anika Therapeutics (ANIK) pay a dividend?

A

There are no upcoming dividends for Anika Therapeutics.

Q

When is Anika Therapeutics (NASDAQ:ANIK) reporting earnings?

A

Anika Therapeutics does not have any upcoming earnings scheduled.

Q

Is Anika Therapeutics (ANIK) going to split?

A

There is no upcoming split for Anika Therapeutics.

Q

What sector and industry does Anika Therapeutics (ANIK) operate in?

A

Anika Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Atrium Therapeutics Inc

NASDAQ:RNA

$13.23

%

Voyager Therapeutics Inc

NASDAQ:VYGR

$3.88

-2.02%

Zentalis Pharmaceuticals Inc

Connect Biopharma Holdings Ltd

NASDAQ:CNTB

$3.69

6.96%

Burning Rock Biotech Ltd

NASDAQ:BNR

$16.36

%

Elicio Therapeutics Inc

NASDAQ:ELTX

$10.44

%

Eledon Pharmaceuticals Inc

NASDAQ:ELDN

$2.80

-1.06%

Key Statistics

Open

$14.72

Close

$14.28

Volume / Avg.

91.77K / 146.36K

Day Range

$14.19 - $14.73

52 Wk Range

7.87 - 15.79

Market Cap

$205.89M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

5.8%

Days to Cover

4.85

Recent Anika Therapeutics Inc News

Top 2 Health Care Stocks That May Crash This Quarter

2 stocks in healthcare sector flashing warning to investors who value momentum. RSI is an indicator that compares stock strength on up and down days.

Avi Kapoor

Anika Therapeutics Cingal Tops Steroid For Osteoarthritis Pain Relief

Vandana Singh

New FDA 510(k) Clearance Expands Anika's Sports Medicine Soft Tissue Portfolio

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

11.19M

Investing Cash Flow (TTM)

-401.00K

Financing Cash Flow (TTM)

-10.55M

Free Cash Flow (TTM)

4.36M

Capital Expenditure (TTM)

-6.83M

Net Change in Cash (TTM)

236.00K

Analyst Trends and Forecast

1

Nov 25

1

Jan

1

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.4

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$166.56M

PE Ratio (TTM)

-

PE Ratio (FWD)

59.17

PEG Ratio (TTM)

5.90

PS Ratio (TTM)

1.88

PB Ratio (TTM)

1.38

Earnings Yield % (TTM)

-4.74%

Earnings Yield % (FWD)

1.69%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

48.52

Book Value / Share

$10.71

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$57.48M

Debt to Equity

0.18

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$14.72

Close

$14.28

Volume / Avg.

91.77K / 146.36K

Day Range

$14.19 - $14.73

52 Wk Range

7.87 - 15.79

Market Cap

$205.89M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

5.8%

Days to Cover

4.85

About

Sector

Health Care

Industry

Biotechnology

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry